Market revenue in 2023 | USD 83.4 million |
Market revenue in 2030 | USD 129.9 million |
Growth rate | 6.5% (CAGR from 2023 to 2030) |
Largest segment | Crohn's disease |
Fastest growing segment | Ulcerative Colitis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Crohn's Disease, Ulcerative Colitis |
Key market players worldwide | AbbVie Inc, Takeda Pharmaceutical Co Ltd, Pfizer Inc, Biogen Inc, Novartis AG ADR, Eli Lilly and Co, UCB SA, Merck & Co Inc, Johnson & Johnson, Celltrion Healthcare |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to inflammatory bowel disease treatment market will help companies and investors design strategic landscapes.
Crohn's disease was the largest segment with a revenue share of 56.59% in 2023. Horizon Databook has segmented the South Africa inflammatory bowel disease treatment market based on crohn's disease, ulcerative colitis covering the revenue growth of each sub-segment from 2018 to 2030.
Large patient pool, high healthcare expenditure, and increased R&D activities by private & government bodies to improve healthcare services are some of the major factors driving the market in South Africa. For instance, incidence of Crohn’s disease ranges from 0.3 to 1.8 per 100,000 population and 0.6 to 2.7 per 100,000 population for ulcerative colitis.
Increasing investments in R&D sector of South Africa targeting improvements in public health services by developing healthcare infrastructure and increasing government focus on development of novel treatment options are expected to boost market growth.
For instance, the South African government has initiated a reimbursement program, “National Health Insurance,” which covers medical expenses in the country, thereby boosting market growth. Moreover, nonprofit organizations aiming to improve quality of patient care are anticipated to boost South Africa market.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa inflammatory bowel disease treatment market , including forecasts for subscribers. This country databook contains high-level insights into South Africa inflammatory bowel disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account